Cardiometabolic Health and Diabetes
FIDELIO DKD Results
Investigator Gerasimos Filippatos, MD summarizes the results of FIDELIO-DKD, which examined whether finerenone affected cardiovascular outcomes in patients with chronic kidney disease and T2DM.
The CVSN Council accelerates the discovery, interpretation, and application of science to enhance cardiovascular health and treat cardiovascular diseases and stroke. The council helps develop scientific statements and advisories, guide professional education activities, provide scientific expertise, conduct research, translate findings, and promote evidence-based practices in clinical settings.
The Council on Lifestyle and Cardiometabolic Health promotes the expansion and exchange of knowledge with the ultimate goal of improving cardiovascular health across the lifespan. The council nurtures basic, clinical, epidemiological, and translational science related to nutrition, lipids, obesity, diabetes, physical activity, and behavioral change.